Philip Brenner

Publikationer
CV
Populärvetenskap och samverkan

Artiklar

Journal article: NEUROSCIENCE APPLIED. 2023;2:102907

Healthcare and psychiatric drug utilization after a suicide attempt in depression: a matched cohort study from Swedish nationwide registers

Johansson V; Brenner P; Karlsson P; Borentain S; Feldman A; Reutfors J
Article: INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE. 2022;26(3):251-258

Health care utilisation in treatment-resistant depression: a Swedish population-based cohort study.

Brenner P; Nygren A; Hägg D; Tiger M; O'Hara M; Brandt L; Reutfors J
Journal article: NEUROSCIENCE APPLIED. 2022;1:100228

Trends in hypnotic drug use in depression 2007 – 2017: a Swedish population-based study

Reutfors J; Brandt L; Cabrera P; Karlsson P; Eloranta S; Brenner P
Article: ARCHIVES OF SUICIDE RESEARCH. 2021;25(3):424-438

Risk Factors for Suicide and Suicide Attempts Among Patients With Treatment-Resistant Depression: Nested Case-Control Study.

Reutfors J; Andersson TM-L; Tanskanen A; DiBernardo A; Li G; Brandt L; Brenner P
Article: THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY. 2021;11:20451253211006508-204512532110065

Excess deaths in treatment-resistant depression.

Brenner P; Reutfors J; Nijs M; Andersson TM-L
Article: BMC PSYCHIATRY. 2020;20(1):232

Risk and risk factors for disability pension among patients with treatment resistant depression- a matched cohort study.

Taipale H; Reutfors J; Tanskanen A; Brandt L; Tiihonen J; DiBernardo A; Mittendorfer-Rutz E; Brenner P
Article: ADDICTION. 2020;115(4):768-777

Substance use disorders and risk for treatment resistant depression: a population-based, nested case-control study.

Brenner P; Brandt L; Li G; DiBernardo A; Bodén R; Reutfors J
Article: DRUG SAFETY. 2020;43(2):135-145

A Post-Authorization Safety Study of Quetiapine as Antidepressant Treatment in Sweden: Nested Case-Control Analyses of Select Outcomes.

Reutfors J; Brenner P; Brody B; Wray H; Andersen M; Brandt L
Article: BMC RHEUMATOLOGY. 2020;4:9

Use of antidepressants and benzodiazepine-related hypnotics before and after initiation of TNF-α inhibitors or non-biological systemic treatment in patients with rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis.

Brenner P; Citarella A; Wingård L; Sundström A
Article: PLOS ONE. 2020;15(7):e0236434

A register-based approach to identifying treatment-resistant depression-Comparison with clinical definitions.

Hägg D; Brenner P; Reutfors J; Li G; DiBernardo A; Bodén R; Brandt L
Article: NEUROLOGY. 2019;93(24):E2216-E2223

Disability worsening among persons with multiple sclerosis and depression: A Swedish cohort study.

Binzer S; McKay KA; Brenner P; Hillert J; Manouchehrinia A
Article: ADDICTION. 2019;114(7):1274-1282

Treatment-resistant depression as risk factor for substance use disorders-a nation-wide register-based cohort study.

Brenner P; Brandt L; Li G; DiBernardo A; Bodén R; Reutfors J
Article: ANNALS OF GENERAL PSYCHIATRY. 2019;18:23

All-cause mortality in patients with treatment-resistant depression: a cohort study in the US population.

Li G; Fife D; Wang G; Sheehan JJ; Bodén R; Brandt L; Brenner P; Reutfors J; DiBernardo A
Article: BMC PSYCHIATRY. 2018;18(1):352

Humanistic outcomes in treatment resistant depression: a secondary analysis of the STAR*D study.

DiBernardo A; Lin X; Zhang Q; Xiang J; Lu L; Jamieson C; Benson C; Lee K; Bodén R; Brandt L; Brenner P; Reutfors J; Li G
Article: JOURNAL OF AFFECTIVE DISORDERS. 2018;238:674-679

Mortality in treatment-resistant unipolar depression: A register-based cohort study in Sweden.

Reutfors J; Andersson TM-L; Brenner P; Brandt L; DiBernardo A; Li G; Hägg D; Wingård L; Bodén R
Article: PSYCHONEUROENDOCRINOLOGY. 2018;89:53-58

Depression and fatigue in multiple sclerosis: Relation to exposure to violence and cerebrospinal fluid immunomarkers.

Brenner P; Granqvist M; Königsson J; Al Nimer F; Piehl F; Jokinen J
Article: EUROPEAN JOURNAL OF NEUROLOGY. 2016;23(8):1329-1336

Multiple sclerosis and risk of attempted and completed suicide - a cohort study.

Brenner P; Burkill S; Jokinen J; Hillert J; Bahmanyar S; Montgomery S
Article: SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY. 2016;51(7):1047-1054

Prescribed psychiatric medication among multiple sclerosis patients before and after disability pension: a register study with matched controls.

Brenner P; Mittendorfer-Rutz E; Jokinen J; Alexanderson K; Hillert J; Tinghög P
Article: BRAIN BEHAVIOR AND IMMUNITY. 2016;51:47-55

Cerebrospinal fluid kynurenines in multiple sclerosis; relation to disease course and neurocognitive symptoms.

Aeinehband S; Brenner P; Ståhl S; Bhat M; Fidock MD; Khademi M; Olsson T; Engberg G; Jokinen J; Erhardt S; Piehl F
Article: BMC PSYCHIATRY. 2015;15:286

Is disability pension a risk indicator for future need of psychiatric healthcare or suicidal behavior among MS patients- a nationwide register study in Sweden?

Björkenstam C; Tinghög P; Brenner P; Mittendorfer-Rutz E; Hillert J; Jokinen J; Alexanderson K
Journal article: NEUROLOGY. 2015;84(14_supplement)

National Swedish MS Register Based Study: the Symbol Digit Modalities Test as a predictor of work disability (P3.222)

Karrenbauer V; Brenner P; Hillert J; Tinghög P
Article: PLOS ONE. 2014;9(8):e104165

Psychiatric diagnoses, medication and risk for disability pension in multiple sclerosis patients; a population-based register study.

Brenner P; Alexanderson K; Björkenstam C; Hillert J; Jokinen J; Mittendorfer-Rutz E; Tinghög P
Visa fler

Alla övriga publikationer

Conference publication: EUROPEAN PSYCHIATRY. 2022;65:S111

Association with severe and treatment-resistant depression among patients with inflammatory joint disease. Nationwide nested case-control study in Swedish registers.

Brenner P; Askling J; Stang P; Brandt L; Hagg D; Reutfors J
Conference publication: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2022;31:368-369

Prescribing patterns for glucagon-like peptide-1 receptor agonists following the introduction of semaglutide in Denmark and Norway

Rasmussen L; Andersen JH; Furu K; Karlstad O; Brenner P; Pottegard A
Conference publication: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2021;53:S77

Health care utilization in treatment-resistant depression: a Swedish population based cohort study

Brenner P; Nygren A; Hagg D; Tiger M; O'Hara M; Brandt L; Reutfors J
Conference publication: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2020;29:70

Excess deaths associated with treatment resistance in patients with major depressive disorder

Brenner P; Brandt L; Nijs M; Reutfors J; Andersson T
Conference publication: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2019;29:S48-S49

Risk for disability pension among antidepressant treated patients with and without treatment resistant depression: matched cohort study in Swedish registers

Taipale H; Reutfors J; Tanskanen A; Tiihonen J; Mittendorfer-Rutz E; DiBernardo A; Brandt L; Brenner P
Conference publication: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2019;28:99

Risk factors for suicide and suicide attempts among patients with treatment resistant depression: A population based nested case-control study

Brenner P; Andersson TM-L; Tanskanen A; DiBernardo A; Li G; Brandt L; Reutfors J
Conference publication: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2018;27:152

Treatment resistant depression as a risk factor for substance use disorders-A national register-based cohort study

Brenner P; Hagg D; DiBernardo A; Li G; Boden R; Brandt L; Reutfors J
Conference publication: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2018;27:153

Substance use disorders are risk factors for treatment resistant depression

Brenner P; Brandt L; Hagg D; Li G; DiBernardo A; Boden R; Reutfors J
KI thesis / dissertation: 2017

Psychiatric comorbidity in multiple sclerosis : biological and epidemiological aspects

Brenner, Philip
Review: ACTA NEUROLOGICA SCANDINAVICA. 2016;134 Suppl 200:47-54

Fatigue and depression in multiple sclerosis: pharmacological and non-pharmacological interventions.

Brenner P; Piehl F
Conference publication: EUROPEAN PSYCHIATRY. 2015;30:616

Psychiatric Drug Consumption Among Multiple Sclerosis Patients Before and After Disability Pension; a Controlled Register Study

Brenner P; Mittendorfer-Rutz E; Jokinen J; Alexandersson K; Hillert J; Tinghog P
Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2015;21:351-352

Cerebrospinal fluid kynurenines in multiple sclerosis: relation to disease course and neurocognitive symptoms

Stahl S; Aeinehband S; Brenner P; Bhat M; Fidock MD; Khademi M; Olsson T; Engberg G; Jokinen J; Erhardt S; Piehl F
Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2015;21:23-24

Multiple sclerosis and risk of completed and attempted suicide - a national cohort study

Brenner P; Burkill S; Jokinen J; Moore A; Geissbuehler Y; Hillert J; Bahmanyar S; Montgomery S
Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2014;20:389

Psychiatric diagnoses, medication and risk for disability pension in multiple sclerosis patients; a population-based register study

Brenner P; Jokinen J; Bjorkenstam C; Hillert J; Rutz EM; Alexandersson K; Tinghog P

Anställningar

Adjungerad Adjunkt, Klinisk neurovetenskap, Karolinska Institutet, 2023-2024

Examina och utbildning

Docent, Psykiatri, Karlinska Institutet, 2022
Medicine Doktorsexamen, Institutionen för klinisk neurovetenskap, Karolinska Institutet, 2017

Handledare

Silvia Segovia Chacón, Pharmacoepidemiological studies of medication use in reproductive-aged and pregnant women: focus on hypnotics and treatments for migraine, https://ki.se/en/people/silvia-segovia-chacon, 2023

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Handledare

Nyheter från KI

Kalenderhändelser från KI